Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance
Klümper, Theresa, Bruckmueller, Henrike, Diewock, Tobias, Kaehler, Meike, Haenisch, Sierk, Pott, Christiane, Bruhn, Oliver, Cascorbi, IngolfVolume:
9
Journal:
Experimental Hematology & Oncology
DOI:
10.1186/s40164-020-00183-1
Date:
December, 2020
File:
PDF, 2.16 MB
2020